Omnicell OMCL EBITDA

EBITDA at other companies

Baxter InternationalBAX

$303M-0.7%

Becton, Dickinson and CompanyBDX

$656M-30.9%

BrightSpring Health Services, Inc.BTSG

$160.54M+72.8%

Cardinal Health, Inc.CAH

$970M+52.3%

ICU MedicalICUI

$88.74M+47.3%

InfuSystem HoldingsINFU

$4.84M+23.0%

FAQ

What is Omnicell's EBITDA?

Omnicell (OMCL) reported EBITDA of $51.25M in Q2 2026.

How has Omnicell's EBITDA changed year-over-year?

Omnicell's EBITDA increased by 84.9% year-over-year, from $27.72M to $51.25M.

What is the long-term trend for Omnicell's EBITDA?

Over 4 years (2021 to 2025), Omnicell's EBITDA has grown at a -15.2% compound annual growth rate (CAGR), from $162.5M to $83.97M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.